James P. Scopa

James P. Scopa, Director at Dice Therapeutics (NASDAQ:DICE), made a large insider buy on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Scopa purchased 6,000 shares of Dice Therapeutics at a...